NCT01148810View on ClinicalTrials.gov

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 15, 2010

Primary Completion Date

June 13, 2012

Study Completion Date

June 13, 2012

Conditions
PolymyositisDermatomyositis
Interventions
DRUG

BAF312

DRUG

Placebo

Trial Locations (6)

1083

Novartis Investigative Site, Budapest

4032

Novartis Investigative Site, Debrecen

17176

Novartis Investigative Site, Stockholm

02115

Novartis Investigative Site, Boston

128 50

Novartis Investigative Site, Prague

M6 8HD

Novartis Investigative Site, Manchester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY